Article

HaaretzHaaretz on 2022-04-24 02:12

From a Lab in Israel: The First Antibody Designed by AI Enters Clinical Trials

Biolojic Design will conduct the trial for cancer patients in Australia with a new type of drug that makes full use of computational biology and big data

Related news